National Institute of General Medical SciencesNational Institutes of Health 45 Center Drive MSC 6200Bethesda, Maryland 20892-6200301-594-0943301-480-2228 (fax)email@example.com
Deputy Director, National Institute of General Medical Sciences
American National Red Cross Blood Research Laboratory, Bethesda, MD
National Institute of Dental Research, National Institutes of Health, Bethesda, MD
National Institute of General Medical Sciences, National Institutes of Health, Bethesda, MD
B.A., Biology, University of Pittsburgh, 1967M.A., Biology, Boston University, 1970Ph.D., Developmental Biology, Bryn Mawr College, 1972
Public Health Service Special Recognition Award, 1991Senior Executive Service Performance Award, 1995, 1996, 1997, 1998, 2000, 2001, 2002, 2003NIH Group Merit Award, 1998NIH Director's Group Award, 1999Senior Executive Service Presidential Meritorious Executive Rank Award, 1999Special Act Award, 2004NIH Director's Award, 2004Special Act Award, 2005Special Act Award, 2006NIH Director's Group Award, 2006Special Act Award, 2007NIH Merit Award, 2007NIH Director's Award, 2008NIGMS Distinguished Service Award, 2013
SELECTED NIH SPECIAL ASSIGNMENTS
Member, Staff Training in Extramural Programs (STEP) Committee, 1986-1989NIH Program Representative to the Federal Demonstration Partnership, 1991-1998Member, Executive Committee, Federal Demonstration Partnership, 1996-1998Detailee (part-time) to Office of Science and Technology Policy, 1993-1994Executive Secretary, Panel to Assess the NIH Investment in Research on Gene Therapy, 1995Member, Search Committee for Director, National Eye Institute, 2000Organizer of First Community Consultation on the Responsible Collection and Use of Samples for Genetic Research, 2000Chair, Trans-NIH Working Group that developed "Points to Consider When Planning a Genetic Study that Involves Members of Named Populations," 2001Detailee (part-time) to Office of the Director, NIH, to establish Human Embryonic Stem Cell Registry, 2001Member and Chair, Stetten Museum Advisory Committee, 2001-2006Member, Title 42 NIH Compensation Committee, 2002-PresentMember, Search Committee for Director, National Institute of Environmental Health Sciences, 2003-2004Organizer of NIH RNAi workshop and inventory to identify research and resource needs related to RNAi technology, 2004 Principal Leader, NIH Director's Pioneer Award Program, 2004-2012Principal Leader, NIH Director's New Innovator Award Program, 2007-2012Member, NIH Peer Review Implementation Cross-Cutting Group, 2008Member, NIH Bioethics Task Force, 2009-PresentMember, NIH Common Fund High Risk-High Reward Working Group, 2011Chair, Steering Committee, Office of Emergency Care Research, 2012-PresentOrganizer, Causal Factors and Interventions Workshop (to Promote Women in Scientific Careers), 2012Member, Advisory Committee to the Director Biomedical Research Workforce Report Pre-implementation Team, 2012
SELECTED NIGMS SPECIAL ASSIGNMENTS
Project Officer, NIGMS Human Genetic Cell Repository, 1984-2011, Alternate Project Officer, 2011-PresentMember, NIGMS Title 42 Compensation CommitteeMember, NIGMS Committee to Evaluate Large Grants MechanismsMember, NIGMS Committee on Minority Program EvaluationMember, Certificate of Confidentiality CommitteeNIGMS Liaison to Trans-NIH Bioethics CommitteeNIGMS Liaison to Trans-NIH Bioethics Committee – Human Data and Specimens SubcommitteeNIGMS Liaison to various trans-NIH working groups for whole-genome association studiesChair, NIGMS Strategic Plan Committee, 2006-2007Member, Portfolio Retreat Committee, 2007Chair, NIGMS Training and Career Development Strategic Plan Committee, 2009-2010Organizer, Advancing Biomedical Research Workforce Diversity: NIGMS Workshop for Postdocs Transitioning to Independent Positions, 2009-2010Chair, Implementation Committee for the NIGMS Strategic Plan for Biomedical and Behavioral Research Training, 2011
Invited speaker at National Academy of Sciences Panel on Biomedical Research Training, 2003Invited speaker on career development in quantitative biology at Burroughs Wellcome Fund Board of Directors Meeting, 2003Invited speaker on outreach to the community for genetic research at Hispanic/Latino GeneticsInvited speaker on community consultation in genetic research, Gordon Conference on Science and Technology Policy, 2004Invited speaker on NIH support for RNAi research to German Minister of Science and German Embassy science and technology staff, 2004Invited speaker on support of high-risk research to delegation of Dutch members of Parliament, 2006Invited speaker on support of high-risk research to National Science Board, 2006Invited speaker on NIH grant support to National Science Foundation-sponsored Women in Science and Engineering Workshop, 2009Invited keynote speaker on NIGMS and its research training strategic plan at the EPSCoR/IDeA Foundation meeting, 2012Invited speaker on the future of model organisms in biomedical research at the Model Organisms to Human Biology Meeting, 2012Invited speaker on NIGMS and its research training strategic plan at the National IDeA Symposium of Biomedical Research Excellence (NISBRE), 2012
Greenberg JH. Aggregation in vitro of immature thrombocytes from early chick embryos. Thromb Diath Haemorrh. 1972;28:14-23.
Greenberg JH, Fletcher AP, Jamieson GA. The presence of glycogen synthase in preparations of platelet plasma membranes. Thromb Diath Haemorrh. 1973;30:307-14.
Greenberg JH, Jamieson GA. The effect of lectins on platelet aggregation and release. Biochim Biophys Acta. 1974;345:231-42.
Hassell JR, Greenberg JH, Johnston MC. Inhibition of cranial neural crest cell development by vitamin A in the cultured chick embryo. J Embryol Exp Morph. 1977;39:267-71.
Greenberg JH, Pratt RM. Glycosaminoglycan and glycoprotein synthesis by cranial neural crest cells in vitro. Cell Differ. 1977;6:119-32.
Greenberg JH, Schrier BK. Development of choline acetyltransferase activity in chick cranial neural crest cells in culture. Dev Biol. 1977;61:86-93.
Greenberg JH, Bader JP. Neural crest cells: temperature-dependent transformation by Rous sarcoma virus. Cell Differ. 1979;8:19-27.
Wilk AL, Greenberg JH, Horigan EA, Pratt RM, Martin GR. Detection of teratogenic compounds using differentiating embryonic cells in culture. In Vitro. 1980;16:269-76.
Greenberg JH, Foidart J-M, Green RM. Collagen synthesis in cultures of differentiating neural crest cells. Cell Differ. 1980;9:153-63.
Greenberg JH, Oliver C. Dimethylsulfoxide reversibly inhibits the pigmentation of cultured neural crest cells. Arch Biochem Biophys. 1980;204:1-9.
Greenberg JH, Seppa S, Seppa H, Hewitt AT. Role of collagen and fibronectin in neural crest cell adhesion and migration. Dev Biol. 1981;87:259-66.
Greenberg JH. Detection of teratogens by differentiating embryonic cells in culture: evaluation as a screening system. Teratogen Carcin Mut. 1982;2:319-23.
Pitha J, Szente L, Greenberg JH. Poly-L-methionine sulfoxide: biologically inert analog of dimethyl sulfoxide with solubilizing potency. J Pharm Sci. 1983;72:665-8.
Jerdan JA, Varner HH, Greenberg JH, Horn VJ, Martin GR. Isolation and characterization of a factor from calf serum which promotes the pigmentation of embryonic and transformed melanocytes. J Cell Biol. 1985;100:1493-8.
Greenberg JH. Special oversight groups to add protections for population-based repository samples. Am J Hum Genet. 2000;66:745-7.
Greenberg JH. The National Institutes of Health announces online availability of "Points to consider when planning a genetic study that involves members of named populations." Am J Hum Genet. 2002;70:1602.
Greenberg JH. Investing in the future: NIGMS strategic plan for biomedical and behavioral research training. The Physiologist 2012;55:146-7.
Rodriguez L, Brooks LD, Greenberg JH, Green ED. The complexities of genomic identifiability. Science 2013; 339:275-6.
Pratt RM, Green RM, Hassell JR, Greenberg JH. Epithelial cell differentiation during secondary palate development. In: Slavkin HC, Greulich RC, editors. Extracellular matrix influences on gene expression. New York: Academic Press; 1975, p. 561-6.
Jamieson GA, Greenberg JH, Smith DF. Adhesion and aggregation phenomena in blood platelets. In: Ulutin ON, editor. Proceedings of the international symposium on blood platelets. Amsterdam: Excerpta Medica; 1974, p. 8-11.
Pratt RM, Wilk AL, Horigan EA, Greenberg JH, Martin GR. Screening for teratogens in vitro. In: Melnick M, Bixler D, Shields ED, editors. Etiology of cleft lip and cleft palate. New York: Alan R. Liss; 1980, p. 169-72.
Greenberg JH, Wilk AL, Horigan EA. Detection of teratogens in vitro using differentiating neural crest cells. In: Gryder R, Frankos VH, editors. Proceedings of the fifth Food and Drug Administration science symposium. The effect of foods and drugs on the development and function of the nervous system: methods for predicting toxicity. Washington, DC: U.S. Department of Health and Human Services; 1980, p. 167-9. HHS Publication No. (FDA) 80-1076.
Greenberg JH. Normal and abnormal differentiation of neural crest cells in culture. In: Pratt RM, Christiansen RL, editors. Proceedings of the international symposium on current research trends in prenatal craniofacial development. New York: Elsevier North Holland; 1980, p. 65-80.
Greenberg JH. Cranial neural crest cells: inhibition of differentiation in culture. In: Mulvihill JJ, Riccardi V, editors. Neurofibromatosis: genetics, cell biology and biochemistry. New York: Raven Press; 1981, p. 105-13.
Greenberg JH. Detection of teratogens by cells in culture. In: Johnson EM, Kochhar DM, editors. Teratogenesis and reproductive toxicology. New York: Springer Verlag; 1983, p. 289-99.
This page last reviewed on
6/5/2015 11:43 AM
Connect With Us: